Thariat J, Bosset M, Falcoz A, Vernerey D, et al. Survival without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial in Head and Neck Cancer Patients with Oligometastases using Stereotactic Ablative Radiotherapy (SABR)-alone or chemotherapy SABR. Int J Radiat Oncol Biol Phys 2024 Nov 27:S0360-3016(24)03651.
PMID: 39612953